Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells
- 1 September 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (5) , 1802-1809
- https://doi.org/10.1182/blood-2001-11-0073
Abstract
Decreased susceptibility to apoptosis and impaired proliferative control are thought to be responsible for prolonged life span and accumulation of chronic lymphocytic leukemia (B-CLL) cells. The activity of calpains (calcium-dependent, neutral proteases, active in the cells responding to signals inducing a rise of cytoplasmic Ca++) is involved in the regulation of apoptosis of some cell types by interaction with caspase-3. This work verifies the hypothesis of the abnormal activity of calpains and its role in reduced apoptosis of the B-CLL cells. Casein zymography, reverse transcriptase–polymerase chain reaction, and Western blotting were used for identification and quantification of the activity and expression of calpains in B-CLL cells and purified normal B lymphocytes. The activity and expression of μ-calpain (requiring micromolar Ca++ for activation) are significantly higher in the leukemic than in nonmalignant cells. Contrarily, the activity and expression of m-calpain (requiring millimolar Ca++) as well as the expression of calpastatin (an endogenous inhibitor of calpains) are unchanged or reduced in the B-CLL lymphocytes. Correspondingly, the activity of caspase-3 is many times lower in the B-CLL cells than in normal B lymphocytes. Inhibition of overexpressed μ-calpain in living B-CLL cells in vitro results in doubling of the proportion of the cells undergoing spontaneous apoptosis. This observation suggests a possible role for calpains in longer survival of the B-CLL cells and may open new therapeutic possibilities.Keywords
This publication has 51 references indexed in Scilit:
- Procaspase-3 and Poly(ADP)ribose Polymerase (PARP) Are Calpain SubstratesBiochemical and Biophysical Research Communications, 1999
- Structure and Physiology of Calpain, an Enigmatic ProteaseBiochemical and Biophysical Research Communications, 1998
- Subcellular Localization and Duration of μ-Calpain and m-Calpain Activity after Traumatic Brain Injury in the Rat: A Casein Zymography StudyJournal of Cerebral Blood Flow & Metabolism, 1998
- REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1996
- Proteolytic processing of nuclear factor κB by calpain in vitroFEBS Letters, 1996
- Calpain Inhibitor-Induced Apoptosis in Human Prostate Adenocarcinoma CellsBiochemical and Biophysical Research Communications, 1995
- Failure of B Cells of Chronic Lymphocytic Leukemia in Presenting Soluble and AlloantigensClinical Immunology and Immunopathology, 1995
- Interferon-α-Mediated Prevention of in Vitro Apoptosis of Chronic Lymphocytic Leukemia B Cells: Role of bcl-2 and c-mycClinical Immunology and Immunopathology, 1994
- Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivoBritish Journal of Haematology, 1994
- The proteolysis of membrane-associated protein kinase C as a possible component of the signalling pathway leading to c-myc induction in B lymphocytesCellular Signalling, 1991